Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report.

Abstract

Ibandronate is a widely used bisphosphonate with no previously well documented hepatotoxicity. We report the first case of ibandronate-related hepatotoxicity and, to our knowledge, the first case of immune-mediated drug-induced liver injury (DILI) related to bisphosphonates. 
DOI: 10.1016/j.jhep.2013.06.003

2 Figures and Tables

Topics

  • Presentations referencing similar topics